How has Meridian Bioscience ROCE changed compared to the previous year?

Return on Capital Employed (ROCE) of Meridian Bioscience changed from 31.02 % to 20.54 %, representing a -33.78% change. The value is lower than the previous year.

What is the Meridian Bioscience ROCE?

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Meridian Bioscience with sector peers and the industry average to assess whether it is attractive.

How does Meridian Bioscience ROCE compare to the industry average?

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Meridian Bioscience ROCE

VIVO

The Return on Capital Employed (ROCE) of Meridian Bioscience (VIVO) as of Jul 19, 2026 is 20.54 %. In the previous year, Return on Capital Employed (ROCE) was 31.02 % — a change of -33.78% (lower).

Get this data via API

Financial Data API

ROCE

20.54 %

YoY

-33.78%

Last updated: Jul 19, 2026

In 2026, Meridian Bioscience's return on capital employed (ROCE) was 20.54 %, a -33.78% increase from the 31.02 % ROCE in the previous year.

Access this data via the Eulerpool API

Docs Get Free API Key

Meridian Bioscience Stock analysis

What does Meridian Bioscience do? Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Meridian Bioscience's Return on Capital Employed (ROCE)

Meridian Bioscience's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Meridian Bioscience's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Meridian Bioscience's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Meridian Bioscience’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Meridian Bioscience ROCE

Meridian Bioscience Stock analysis

ROCE Details

Unraveling Meridian Bioscience's Return on Capital Employed (ROCE)

Year-to-Year Comparison

Impact on Investments

Interpreting ROCE Fluctuations

Frequently Asked Questions about Meridian Bioscience stock

What is the Meridian Bioscience ROCE 2026?

How has Meridian Bioscience ROCE changed compared to the previous year?

How has Meridian Bioscience ROCE developed historically?

What is the Meridian Bioscience ROCE?

What is a good ROCE?

How does Meridian Bioscience ROCE compare to the industry average?

Profitability — Meridian Bioscience

All Key Metrics — Meridian Bioscience

Valuation

Income Statement

Margins

Balance Sheet

Cash Flow

Profitability

Leverage

Growth

Dividend

Workforce

Quality

Other